To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture
NCT: NCT06404372 · COMPLETED
Brief Summary
The clinical trial, sponsored by Sutura Medical Technology, Inc., is a pivotal, blinded, multi-center study assessing the safety and effectiveness of the Demetech Barbed PDO Suture, an absorbable Polydioxanone suture, for the temporary treatment of midface wrinkles. The trial will enroll 57 subjects across up to four sites, following them over a 12-month period to evaluate improvements in wrinkles based on the Lemperle Classification Facial Wrinkle Scale. Primary endpoints include assessing the rate of adverse events and a significant reduction in wrinkle severity at 6 months, with secondary endpoints focusing on longer-term results and patient satisfaction.
Frequently Asked Questions
What is To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture?
To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture is a clinical trial registered under NCT06404372. Current status: COMPLETED.
What is the status of NCT06404372?
The current status of NCT06404372 (To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture) is: COMPLETED.
When did To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture start?
To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture started on 2022-07-18.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.